These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8174475)

  • 21. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C].
    Wei C; Tang ZY; Liu KD
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):676-9, 709-10. PubMed ID: 7866903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of functional CD40 in human hepatocellular carcinoma.
    Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
    Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J; Diao Z; Deng X; Zhong H; Yao W; Hu X
    Oncol Rep; 2007 Jul; 18(1):279-85. PubMed ID: 17549380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency.
    Yanai H; Nakamura K; Hijioka S; Kamei A; Ikari T; Ishikawa Y; Shinozaki E; Mizunuma N; Hatake K; Miyajima A
    J Biochem; 2010 Jul; 148(1):85-92. PubMed ID: 20356822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
    Gao FJ; Cui SX; Chen MH; Cheng YN; Sun LR; Ward SG; Kokudo N; Tang W; Qu XJ
    Life Sci; 2008 Dec; 83(23-24):815-20. PubMed ID: 18976674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
    Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
    Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
    Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR
    Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
    Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
    Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Nishioka M; Tan EM
    Int J Oncol; 2005 Feb; 26(2):311-7. PubMed ID: 15645114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of radiolabeled anti-HBx monoclonal antibody for HCC targeting therapy].
    Li J; Tang Z; Liu K
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):271-4. PubMed ID: 8758272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y; Yasumura S; Nambu S; Yoshio Y; Murakami J; Takahara T; Higuchi K; Watanabe A; Miyata K; Kato M
    Hepatology; 1998 Jul; 28(1):57-67. PubMed ID: 9657097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance].
    Sui Y; Sun Z; Chen Z
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.